RW
Ryan J. Watts (President and CEO) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Denali Therapeutics Inc. (DNLI). The largest single filing was $581K of DNLI (35,198 sh × $16.50, as filed), executed Jan 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
1
0 buys · 1 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$581K
shares × price, as filed
Last traded
Jan 6
Filed Jan 8
Median ADV $37.0M across their filed names
Open performance→Volume by month
Buys $0
Sells $8.8M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 12 months
Most traded names
DNLI
Denali Therapeutics Inc.
DNLI · 0 buys · 3 sells
3 filings
Recent filings
DNLISALE
Denali Therapeutics Inc.
View filing →
$581K35,198 sh × $16.50
Exec Jan 6
Filed Jan 8 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $7.4M
495,282 sh × $15.00
Exec Jul 9 2025
Filed Jul 11 2025 · 5:30 PM ET DNLISALE Denali Therapeutics Inc. View filing → $751K
36,916 sh across 2 lots
Exec Jan 6 2025
Filed Jan 8 2025 · 5:30 PM ET